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Abstract
The normalization of cellular glucose assimilation is the basic aim of metabolic therapy in type 2 diabetes mellitus (T2DM). It requires
parallel changes in the process of cellular glucose transport (CGT).
This review presents the pathophysiological and clinical outlines of CGT. Sequentially, the advances in the mechanisms and classification
of CGT and their physiological and molecular base are described. The role of CGT pathogenetic significance in diabetes mellitus is stressed.
Finally, the opinion is expressed that the CGT study is a potentially important approach to clinical interpretation of glucose metabolism
disturbances and their pharmacotherapy. (Pol J Endocrinol 2010; 61 (3): 303–310)
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Streszczenie
Podstawowym celem metabolicznego wyrównania cukrzycy typu 2 jest normalizacja komórkowego pobierania glukozy, która jest moż-
liwa dzięki zmianom w procesie dokomórkowego transportu glukozy (CGT, cellular glucose transport).
W opracowaniu przedstawiono zarys patofizjologicznych i klinicznych problemów dokomórkowego transportu glukozy. Kolejno opisa-
no postępy badań dotyczących mechanizmów i rodzajów CGT, ich molekularną fizjologię oraz potencjalną rolę CGT w patogenezie
cukrzycy.
Wyrażono opinię, że badania CGT stanowią nowy, potencjalnie bardzo istotny sposób ujęcia zaburzeń metabolizmu glukozy oraz farma-
koterapii. (Endokrynol Pol 2010; 61 (3): 303–310)
Słowa kluczowe: dokomórkowy transport glukozy, insulina, szlak przekaźnictwa sygnału, cukrzyca
Introduction
Cellular glucose transport (CGT) and the regulation of
this process in the human organism are the subjects of
many studies. The significance of the glucose transport
studies does not result only from their cognitive values
but also from the therapeutic benefits that they can
uncover. In the pathogenesis of diabetes mellitus 2,
metabolic syndrome, and other clinical conditions re-
lated to insulin resistance, disorders of cellular glucose
transport play the most fundamental role.
In Poland, there is a historical tradition of studies in
this area, which is also recognized throughout the
world. In Warsaw and Łódź, the scientific basis for the
studies of cellular glucose transport was created by the
physiologist Mieczysław Wierzuchowski (1895–1967).
He conducted studies on cellular glucose transport on
the model of phlorizin diabetes. Phlorizin selectively
inhibits glucose transport in the tubule cells of the neph-
rons. Therefore, Wierzuchowski’s studies concerned the
role of the kidneys in the shaping of glucose metabo-
lism. For many years, particular problems in the area of
cellular glucose transport have been a major area of re-
search work in the centre which presents this review.
The dynamically increasing data in the area of cellu-
lar glucose transport have underlined the general signif-
icance of this process. For example, the disturbances may
have an aetiological role in insulin resistance syndromes.
Molecular physiology of glucose transport
Almost all of the biological membrane transport pro-
cesses employ specific membrane proteins, often in
combination with the receptors or receptor domains
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located outside of the cytoplasm, as well as with the
proteins or cytoplasmatic domains which play a regu-
latory role or supply energy [1]. Each of these systems
of proteins or accompanying structures is called a trans-
porter, transport system, or carrier. A transporter is,
therefore, a protein or a system of proteins that cata-
lyzes the directional reaction or movements of the mol-
ecule, e.g. glucose. These proteins can also catalyze an-
other chemical reaction and electron transfer. Transport
systems can be considered as proteins or protein com-
plexes having catalytic properties analogous to enzymes
or enzyme complexes [2].
Substance transport involving a specialized trans-
porter can proceed in different, but interconnected,
ways. The first way is a facilitated diffusion, a process
that does not need energy. In biological systems, two
kinds of facilitated diffusion have been detected: chan-
nel-type facilitated diffusion and carrier-type facilitat-
ed diffusion.
In channel-type facilitated diffusion, the substance goes
through the membrane via a transmembrane channel
formed by proteins (appropriately, hydrophilic for hydro-
philic substances, hydrophobic for hydrophobic substanc-
es, and amphipathic for amphipathic substances). The struc-
tures of several such channel proteins have been studied
and explained by means of X-ray crystallography [1, 2].
This biological interpretation of the cellular glucose
transport is presented in Figure 1, 2, and Table I.
In the carrier-type facilitated diffusion, the transport-
er alters its conformation, allowing the transmembrane
substrate to transport. However, this is only a theoreti-
cal discussion as none of the described carriers has been
studied with the use of X-ray crystallography. With the
help of computer software, a dimensional model of the
glucotransporter GLUT l molecule has been created,
allowing the reconstruction of the structure of the pro-
tein on the basis of its amino acid sequence and its sim-
ilarity to already known molecules [3].
Substrate transport by the carrier is usually several
times slower than the speed achieved by the channels.
Additionally, in contrast to most of the channels, the car-
riers display specificity of dimensional structure of the
substrate. All kinds of transporters can be characterized
by saturation kinetics. Nevertheless, this feature is more
characteristic for carriers. Very few of them display the
ability to function by the same rules as channels, and
among those that possess this ability, it occurs only after
the covalent or noncovalent ligand binding or after
a build-up of high membrane potential. Most of the chan-
nels exist in the form of oligomeric complexes, while most
of the carriers can function in the form of monomeric
proteins. Such observations lead to the conclusion that
channels and carriers (and their functions) differ [4].
If, at the time of transmembrane transport of a sub-
stance (glucose), an expenditure of energy occurs, the
system catalyzing such a reaction becomes an active
Figure 1. Overview of the cellular transport of glucose
Rycina 1. Schemat dokomórkowego transportu glukozy
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transporter. Primary active transport is such a system
in which the energy is drawn from a primary source
(e.g. chemical energy, photon energy, or the flow of elec-
trons). In secondary active transport, the energy is tak-
en from secondary sources, e.g. electrochemical ion gra-
dient (protons: proton motive force — PMF, or sodium
motive force — SMF). A secondary energy source comes
into being using the energy from a primary source [4].
Active transporters can function on the basis of un-
iport, symport, and antiport. Uniporters catalyze the
transport process of one type of molecule, so it is con-
ducted independently of the movement of other mole-
cules. Symporters, classically called cotransporters, cat-
alyze the transport of molecules of two or more types
in the same direction. Single-point mutation in the sym-
porter can change such a carrier into a uniporter, which
proves that these two types of carriers do not differ
Table I. Types of glucose transport in live organisms
Tabela I. Rodzaje transporu glukozy w organizmach żywych
• Physicochemical transport, harmonious with the laws of
diffusion, constitutes about 5% of transport necessary for the
metabolism. This is so because of the lipid, structure of the
cellular membrane, makes them practically impenetrable for
glucose
Physicochemical cellular glucose transport = the difference
of glucose concentrations on both sides of the cellular
membrane x membrane penetrability
• Biological transport, biological diffusion, and facilitated
transport covers about 95% of cellular glucose transport
necessary for metabolism. It is physiologically regulated.
Its activity is specific to various types of cells and their
functioning
Biological cellular glucose transport = the difference of
glucose concentrations on both sides of the cellular membrane
x biological activity of specific transport systems x availability
of energy for the functions
Fig. 2. Insulin signalling pathways. The sequence of events starts with the binding of the insulin molecule to the a subunit of its
receptor. This reaction activates signal proteins from the insulin receptor substrate (IRS) family. From this initial signalling event,
further signals  travel down the signalling pathway, are multiplied, and are directed toward different effectors — glucose transport,
metabolic processes, and mitogenesis (acc. to 1)
Rycina 2. Przekazywanie sygnałów insulinowych. Sekwencja zdarzeń rozpoczyna się od przyłączenia cząsteczki insuliny do podjednostki
a jej receptora. Ta reakcja aktywuje białka sygnałowe z rodziny substratów receptora insulinowego (IRS). W dalszej kolejności sygnały
zostają przekazane dalej, wzdłuż szlaku sygnałowego, ulegają zwielokrotnieniu i powodują wiele różnych efektów, wpływają między
innymi na transport glukozy, procesy metaboliczne oraz mitogenezę
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much. Antiporters, also called counter-transporters or
exchangers, catalyze the reaction of changing molecules
of one or more types into different molecules [5].
In human cells there are two families of proteins
which are responsible for cellular glucose transport.
These are:
— glucose transporter systems from the group of
GLUT1–14 peptides (glucotransporters);
— sodium/glucose transporters (SGLT, Na+/glucose
cotransporters).
Expression of particular GLUT protein coding genes
is specific for tissues and cells [6–11].
GLUT protein glucose transport corresponds to facili-
tated diffusion. SGLT protein cellular glucose transport is
a secondary, active sodium transport combined process.
All the membrane transport systems were gathered
and classified in the transporter classification, or TC. This
classification system partially corresponds to the en-
zyme classification system, but in contrast to the latter,
it is not based solely on the protein function but also on
the phylogenesis. Transporters were grouped accord-
ing to five criteria: V — transporter class, W — trans-
porter subclass, X — transporter family or superfamily,
Y — family or subfamily, and Z — substrate or range of
substrates transported, direction of the transport (in-
tra- or extracellular). Each transporter subclass has
a two-digit number in the TC classification (V.W), and
each family a three-digit number (V.W.X) [5].
As mentioned previously, glucose and other hexose
transmembrane transport occurs thanks to proteins
from two different families: GLUT and SGLT. Glucose
transport harmonious with volume gradient, without
energy, occurring due to the process of facilitated dif-
fusion, takes place through the work of carriers belong-
ing to the GLUT family transporters, which are present
on the surface of all cells of an organism. Facilitated dif-
fusion, which undergoes saturation, is stereoselective
and is two-directional. The second family of transport-
ers, represented by e.g. Na+/glucose intestinal cotrans-
porter (SGLT1), uses the electrochemical sodium ion
gradient to transport glucose and galactose, contrary
to their volume gradient. SGLT1 is responsible for the
collection of glucose and galactose from nutrients found
in the intestinal lumen as well as for re-absorption of
these sugars from primary urine in the nephron. In the
renal proximal tubule, two other transporters belong-
ing to this family exist: SGLT2and SGLT3 [12–14].
The characteristics of these two types of glucose
transporters are presented below.
Transporters from the GLUT family
Currently, 13 genes are known that code the homolog-
ical but different proteins transporting glucose and oth-
er hexoses to cells with the use of facilitated diffusion.
These genes, in accordance with the assumed nomen-
clature (HUGO Gene Nomenclature Committee), are
described as SLC2A1-SLC2A13 (Solute Carrier Family
2A). Proteins coded by these genes are accordingly:
GLUT1-GLUT12 and HMlT 1 [15].
In the literature concerning glucose transporters,
there is considerable variety relating to the nomencla-
ture of the genes and GLUT proteins coded by these
genes. In this study, the nomenclature of genes and
proteins (Tables II, III, and Fig. 3) proposed by Joost and
Thorense has been assumed [15].
The first carrier that became a model for the studies
of the structure and characteristics of glucose transport-
ers in mammals was isolated from erythrocytes [16].
Purification and determination of the part of the amino
acid sequence from human erythrocytes and the use of
antibodies against these proteins allowed isolation of
cDNA glucose transporter clones from human HepG2
cells and rat’s brain [17, 18]. This protein, built from
492 amino acids of molecular mass of 45 or 55 kDa (de-
pending on the level of glycolization) is currently called
GLUT1. The dimensional orientation model of GLUT l
in cellular membrane assumes the occurrence of
12 transmembrane segments with a-helix structure
(TMH, transmembrane helices) and with N and C ter-
mini located intracellularly.
Apart from a large intracellular loop linking seg-
ments 6 and 7, and dividing the whole structure into
two parts, the loops on the cytoplasmic surface are very
short, amounting to 8-12 amino-acid residues. These
short loops are a considerable limitation for tertiary pro-
tein configuration and cause a very tight packing of
helical segments on the internal side of the membrane.
The length of the loop on the external surface is larger
than on the cytoplasmic surface, which results in a looser
packing on the external side. Limitations resulting from
the presence of short linking loops of the transporter
occur between the 460th and 480th amino-acid residues.
Substitution of the last 45 amino acids of GLUTl with
the use of the appropriate region of GLUT2 protein
caused the occurrence of chimeric protein of about four
times larger Km and Vmax values. Since the substitution
of C terminus of GLUTl protein by means of GLUT2
terminus caused the occurrence of a protein with ki-
netic characteristics similar to the ones possessed by
GLUT2, it seems that C terminus is responsible, at least
partially, for the characteristic features of a given iso-
form, probably through direct influence on the glucose
binding site placed on the internal side of the mem-
brane, which influences the speed of release of glucose
from the internal binding site [19].
The results of studies of glucose transporters fully
confirm the hypothesis that glucose transporters are
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Table II. List of mammalian glucose transporter proteins
Tabela II. Białka transporujące glukozę występujące u ssaków
Isoform Tissue distribution Function
GLUT1 Widely distributed in foetal and adult tissues, Basal glucose uptake; increased glucose for
abundant in human erythrocytes, placenta,  growing/dividing cells; upregulated in
microvasculature, immortalized cell lines many tumours; uptake across blood-brain barrier
and other barrier tissues
GLUT2 Hepatocytes, intestinal mucosa, High-capacity, low-affinity transport system;
renal tubules, brain  transepithelial transport (basolateral membrane);
often expressed in parallel with glucokinase; may be
involved in glucose sensing
GLUT3 Widely distributed in foetal and adult Basal glucose uptake in many human cells;
tissues, restricted to brain in some other species  uptake from cerebral fluid into brain parenchymal cells
GLUT4 Skeletal muscle, heart, adipocytes Insulin-responsive glucose transport; important in
whole-body glucose homeostasis
GLUT5 Jejunum, spermatozoa, adipose, muscle, Fructose transport
brain, and kidney tissues
GLUT6 Spleen, leukocytes, brain Unknown
GLUT7 Unknown Unknown
GLUT7 Testis, blastocyst, brain Unknown
GLUT7 Liver, kidney Unknown
GLUT7 Liver, pancreas Unknown
GLUT7 Heart, skeletal muscle Unknown
GLUT7 Heart, prostate Unknown
built from two major domains composed of a-helical
segments: 1–6 (N terminus) and 7–12 (C terminus). Half
of the protein plays a structural role and is essential for
the proper build-in into the cellular membrane, while
the half closer to the C terminus contains the region
involved in glucose molecule transport. With this
assumption, transmembrane segments 7–11 can create
a part of the water channel through which glucose is
transferred [20]. Segment 10 can also play a significant
role in the glucose transport process, probably as the
dynamic element, the movement of which allows the
glucose binding structures to change places on the in-
side and outside. This region contains the conserved
motif GPXPIP, which can supply this glucose transport
fragment with a large degree of mobility and creates the
possibility of conformative changes accompanying glu-
cose molecule transport [21]. The intracellular segment
on C terminus also plays an important role in the change
of internal and external glucose binding sites, probably
through direct interaction with the short intracellular
segment which links TMH 10 and TMH 11 [22].
Transporters from the Sodium/Glucose
Transporters — SGLT family
Proteins from the SGLT family take part in the second-
ary active transport of glucose. They draw their energy
from the electrochemical Na+ ion gradient, sustained
Table III. Characteristics of the GLUT family glucotrans-
porters
Tabela III. Charakterystyka rodziny transporterów glukozy
GLUT
A group of specific, specialized, GLUT transporters:
• the group covers 14 peptide glucose transporters described
as the GLUT family
• they create channels in the membranes, penetrable by glucose
• they undergo genetic, hormonal (insulin), and substrate
regulation
• their function is correlated with the functional state of the cells
• they are specific for various types of cells
• disorders can cause pathological states
Molecular features of GLUT:
• molecules of the transporters from the GLUT family present
themselves as polypeptic chains containing transmembrane
domains, which means fragments of molecules penetrating
cellular membranes, terminal residues — NH3 and COOH.
They can undergo glycolization in loop l or 9
• 14 isoforms of GLUT transporters have been identified in
humans (GLUT1–GLUT12 and GLUT14 as well as the HMIT
transporter)
• Their biosynthesis and action are regulated by SLC2A1–
–SLCA14 genes
• the amount of GLUT molecules is regulated by many factors:
oncogenes, insulin, IGF-1 and IGF-2 growth factors as well as
other growth factors, glucocorticosteroids and glycaemic
unsteadiness
• regulation of glucose transporters is specific for every tissue
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by Na+/K+-ATPase present in the peripheral basement
membrane of epithelial cells. The activity of SGLT1 is
proven by the fact that blockage of GLUT2 in the pe-
ripheral basement membrane of an intestinal epithelial
cell causes a level of cytoplasm glucose concentration
that is 30-fold higher [than what? than normal?]. SGLT
in enterocytes occurs also on the membrane of cyto-
plasmic sacs. They can fuse with cellular membrane,
which causes an increase of SGLT volume on the sur-
face of the cell [23].
In the peptide structure of the sodium-glucose con-
transporters (SGLT), one may delineate 14 domains in
the form of a-helisa positioned in the cellular mem-
brane. The best known is the physiology of SGLT1 and
SGLT2.
Transporters from the same family are also present
in the kidney, and the glucose reabsorption model in
the kidney resembles the one originally proposed for
the small intestine. Glucose gathers inside epithelial cells
thanks to the Na+/glucose cotransporter present in the
brush border membrane, and is then transported out-
side the cell by the GLUT2 uniporter located in the pe-
ripheral basement membrane. There is interesting ge-
netic evidence proving that two types of SGLT are
present in the human kidney. Patients with familial re-
nal glucosuria do not display intestinal glucose absorp-
tion disorders, while patients with glucose-galactose
malabsorption (CGM) display only slight renal
glucosuria. This supports the claim that the major in-
testinal Na+/glucose cotransporter plays only a small
role in renal reabsorption of glucose. It is assumed that
most of the filtered glucose undergoes reabsorption in
the proximal convoluted tubule with the involvement
of SGLT of low affinity and high capacity, described as
SGLT2. The remaining glucose undergoes reabsorption
by the symporter with a high affinity of SGLT1 [24].
Apart from SGLT l and SGLT 2, the SGLT family
encompasses Na+/glucose cotransporter with low affin-
ity; — SGLT 3, inositol transporter — SMIT, iodide trans-
porter — N1S, and vitamin transporter — SMVT (Ta-
bles IV and V).
Kinetic similarities between SGLTI, SGLT3, and oth-
er proteins from the SGLT l family (SMIT and NIS) point
to a similar transport mechanism. Similar to the case of
the GLUT family, transporters of compounds other than
glucose are also a part of the SGLT family. Apart from
those listed in the table, more than 50 proteins belong-
ing to the SGLT family have been discovered occurring
in different organisms,.
Human SGLTI was isolated for the first time from
the intestinal cDNA library with the use of a rabbit
SGLTI probe.
Northern blot analysis showed that the SGLT1 gene
undergoes expression in the ileum as well as in the small
intestine, renal cortex, and the external part of rabbit
renal medulla. SGLT2 was isolated from the human re-
Figure 3. Structure and function of the GLUT4 transporter.
Rycina 3. Budowa i czynność transportera GLUT4
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nal cDNA library. In humans, the gene of this trans-
porter undergoes expression in the renal cortex and, to
a significantly smaller extent, in the intestine. SGLT3
was isolated from a pig kidney epithelial cell line with
the use of a rabbit SGLTI probe and was first named
SAATl then, later on, pig SGLT2. Pig SGLT3 is expressed
Table V. Physiology of transporters from the SGLT transporter family (Sodium/Glucose Transporters)
Tabela V. Fizjologia transporterów glukozy należących do rodziny SGLT
Transporter Substrate of the transport process Localization in a human organism
SGLT1 Na+/glucose Small intestine and S3 segment of nephron
SGLT2 Na+/glucose S1 segment of nephron
SGLT3 Na+/glucose Kidney
SMIT Na+/myoinositol Kidney
NIS Na+/iodide Thyroid
SMVT Pantothenic acid ?
Table IV. Biological characteristics of the SGLT transporters
family (Sodium/Glucose Transporters)
Tabela IV. Biologiczne właściwości rodziny transporterów
SGLT
I. Sodium-glucose transporter 1 — SGLT1:
• protein molecule with a molecular weight of 52 Kd
• the value of Km is 0.35 mU
• the highest concentration exists in the heart, the next highest
in cells of renal tubules and in enterocytes of the jejunum
• SGLT1 expression is regulated by the gene [correct?] located
at chromosome 22q13.1
II. Sodium-glucose transporter 2 — SGLT2:
• protein molecule acting as transporter in renal tubules,
enterocytes (jejunum), and myocytes of skeletal muscles
• the value of Km is 1.64 mU
• the deficit of SLGT1and SGLT2 action in nephrons causes the
renal glucosuria. This is due to the decrease of glucose
reabsorption
• this deficit in enterocytes (jejunum) contributes to glucose
malabsorption
in the kidney, intestine, liver, and spleen. There is not
much information on the translation of SGLT trans-
porter mRNA in the human kidney because there are
no proper antibodies to differentiate these three pro-
teins [25].
Conclusions
The cellular membrane is built mainly from lipids. Due
to this fact, it is almost nonpermeable for glucose on
the basis of physicochemical mechanisms. The delivery
of glucose from the extracellular space to the cell interi-
or is adequate for the physiological needs. Its utiliza-
tion is dependent on biological transport mechanisms.
They are based on two systems of biological transport-
ers: the group of glucotransporters GLUT, and the
group of SLGT transporters. The cells of different tis-
sues express the glucotransporter molecules in a way
corresponding to their functional specialization.
They act in a special, functional way depending on
genetic, substrate, and hormonal regulation. The dis-
turbances in the glucose transporters may be the main
cause for frequent and clinically important pathogenetic
mechanisms like insulin resistance presenting diabetes
mellitus, and in many other clinical insulin-resistant
syndromes. Cellular glucose transport is also the target
for pharmacotherapy. Research in this area is develop-
ing quickly.
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